BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32797735)

  • 1. Role of prophylactic and therapeutic red blood cell exchange in pregnancy with sickle cell disease: Maternal and perinatal outcomes.
    Yılmaz Baran Ş; Kozanoğlu İ; Korur A; Doğan Durdağ G; Kalaycı H; Alemdaroğlu S; Asma S; Kılıçdağ EB; Boğa C
    J Clin Apher; 2021 Jun; 36(3):283-290. PubMed ID: 32797735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic red blood cell exchange may be beneficial in the management of sickle cell disease in pregnancy.
    Asma S; Kozanoglu I; Tarım E; Sarıturk C; Gereklioglu C; Akdeniz A; Kasar M; Turgut NH; Yeral M; Kandemir F; Boga C; Ozdogu H
    Transfusion; 2015 Jan; 55(1):36-44. PubMed ID: 25070465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of high risk pregnancy in sickle cell disease by a strategy of prophylactic red cell transfusion or automated red cell exchange].
    Driss F; Tertian G; Becquemont L; Haddad B; Cynober T; Raphael M; Tchernia G
    Transfus Clin Biol; 2007 Oct; 14(4):386-92. PubMed ID: 18035571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
    Koshy M; Burd L; Wallace D; Moawad A; Baron J
    N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis.
    Vianello A; Vencato E; Cantini M; Zanconato G; Manfrin E; Zamo A; Zorzi F; Mazzi F; Martinelli N; Cavaliere E; Monari F; Venturelli D; Ferrara F; Olivieri O; De Franceschi L
    Transfusion; 2018 Sep; 58(9):2192-2201. PubMed ID: 29984534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.
    Howard RJ; Tuck SM; Pearson TC
    Br J Obstet Gynaecol; 1995 Dec; 102(12):947-51. PubMed ID: 8652484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of sickle cell disease during pregnancy: experience in a third-level hospital and future recommendations.
    Montironi R; Cupaiolo R; Kadji C; Badr DA; Deleers M; Charles V; Vanderhulst J; El Kenz H; Jani JC
    J Matern Fetal Neonatal Med; 2022 Jun; 35(12):2345-2354. PubMed ID: 32627603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study.
    Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF
    J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a prophylactic transfusion program on obstetric outcomes in pregnant women with sickle cell disease: A single centre retrospective cohort study.
    Sobczyk O; Gottardi E; Lefebvre M; Canouï-Poitrine F; Jebali A; De Luna G; Pirenne F; Redel D; Galacteros F; Boutin E; Bartolucci P; Haddad B; Habibi A; Lecarpentier E
    Eur J Obstet Gynecol Reprod Biol; 2023 Nov; 290():103-108. PubMed ID: 37776703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic transfusion for pregnant women with sickle cell disease: a systematic review and meta-analysis.
    Malinowski AK; Shehata N; D'Souza R; Kuo KH; Ward R; Shah PS; Murphy K
    Blood; 2015 Nov; 126(21):2424-35; quiz 2437. PubMed ID: 26302758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion practices in the care of pregnant women with sickle cell disease in Ouagadougou.
    Zamané H; Sanou F; Kiemtoré S; Kain DP; Sawadogo AK; Bonané-Thiéba B
    Int J Gynaecol Obstet; 2019 Dec; 147(3):363-367. PubMed ID: 31489626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective prophylactic transfusion in sickle cell disease.
    Grossetti E; Carles G; El Guindi W; Seve B; Montoya Y; Creveuil C; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(10):1090-4. PubMed ID: 19639465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for Prophylactic Transfusion during Pregnancy for Women with Sickle Cell Disease.
    Whittington JR; Magann EF; Ounpraseuth ST; Chang JN; Whitcombe DD; Morrison JC
    South Med J; 2021 Apr; 114(4):231-236. PubMed ID: 33787937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy in the Sickle Cell Disease and Fetomaternal Outcomes in Different Sickle cell Genotypes: A Systematic Review and Meta-Analysis.
    Aghamolaei T; Pormehr-Yabandeh A; Hosseini Z; Roozbeh N; Arian M; Ghanbarnezhad A
    Ethiop J Health Sci; 2022 Jul; 32(4):849-864. PubMed ID: 35950054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusions.
    Ngô C; Kayem G; Habibi A; Benachi A; Goffinet F; Galactéros F; Haddad B
    Eur J Obstet Gynecol Reprod Biol; 2010 Oct; 152(2):138-42. PubMed ID: 20846778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of continuous flow erythrocytapheresis in pregnant patients with sickle cell disease.
    Morrison JC; Morrison FS; Floyd RC; Roberts WE; Hess LW; Wiser WL
    J Clin Apher; 1991; 6(4):224-9. PubMed ID: 1816244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indications for blood transfusion in pregnancy with sickle cell disease.
    El-Shafei AM; Kaur Dhaliwal J; Kaur Sandhu A; Rashid Al-Sharqi M
    Aust N Z J Obstet Gynaecol; 1995 Nov; 35(4):405-8. PubMed ID: 8717565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of prophylactic partial exchange tranfusion in pregnancies associated with sickle cell hemoglobinopathies.
    Morrison JC; Wiser WL
    Obstet Gynecol; 1976 Nov; 48(5):516-20. PubMed ID: 980280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of exchange transfusion for prevention of complications during pregnancy of sickle hemoglobin C disease patients.
    Benites BD; Benevides TC; Valente IS; Marques JF; Gilli SC; Saad ST
    Transfusion; 2016 Jan; 56(1):119-24. PubMed ID: 26337929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct maternal and fetal pregnancy outcomes in women with sickle cell disease can be predicted using routine clinical and laboratory data.
    Malinowski AK; Kuo KHM; Tomlinson GA; Palcu P; Ward R; Shehata N
    Br J Haematol; 2021 Sep; 194(6):1063-1073. PubMed ID: 34124774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.